MRC Clinical Trials Unit as the London Hub for Trials Methodology Research

A clinical trial is only as reliable as the methods used to design, run, and analyse it, and this project aims to fix the hidden flaws in those methods. Clinical trials are the backbone of evidence-based medicine, but their results can be undermined by poor design—biased patient selection, flawed statistical analysis, or inefficient data collection. This research treats trial methodology itself as a science, systematically testing and improving the tools researchers use. The London Hub for Trials Methodology Research will develop better statistical models, more efficient trial designs, and clearer reporting standards. If successful, the work will not produce a new drug or device directly. Instead, it will improve the infrastructure that quietly determines whether a promising treatment reaches patients or gets abandoned. Better methodology means fewer wasted trials, faster answers to urgent medical questions, and more trustworthy results for doctors and regulators. The hub will also train the next generation of methodologists, embedding rigorous standards across the UK’s clinical research ecosystem. For patients, the payoff is indirect but profound: treatments that work, proven by trials that are harder to get wrong.